Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC September Update

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Arirpiprazole (Abilify®) has been rejected for the treatment of moderate to severe manic episodes in bipolar 1 disorder and for the prevention of a new manic episode because the economic analysis was not sufficiently robust to gain acceptance.

Ropinirole prolonged release (Requip XL®) has been accepted for the treatment of idiopathic Parkinson’s disease in patients already taking ropinirole immediate release tablets and have attained adequate symptomatic control.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC September Update' on Email Share 'SMC September Update' on Delicious Share 'SMC September Update' on Digg Share 'SMC September Update' on Facebook Share 'SMC September Update' on Google+ Share 'SMC September Update' on reddit Share 'SMC September Update' on StumbleUpon Share 'SMC September Update' on Twitter

atomic-wealth

No Comments to “SMC September Update”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,524 spam comments.

atomic-wealth
fond-illness
summer